Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Clinical trial NCT00925600 · COMPLETED

Trial details

NCT number: NCT00925600
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Cataract Low Bone Mineral Density Osteopenia Osteoporosis Prostate Cancer

Start date: 2009-11-30
Primary completion: 2016-05-12
Enrollment: 769

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.